Luzu Approval History
- FDA approved: Yes (First approved November 14th, 2013)
- Brand name: Luzu
- Generic name: luliconazole
- Dosage form: Topical Cream
- Company: Valeant Pharmaceuticals International, Inc.
- Treatment for: Tinea Corporis, Tinea Pedis, Tinea Cruris
Luzu (luliconazole) Cream is an azole antifungal indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis.
Development History and FDA Approval Process for Luzu
|Feb 22, 2018||FDA Approves Expanded Use of Luzu (luliconazole) Cream in Pediatric Patients with Athlete’s Foot, Jock Itch and Ringworm|
|Nov 15, 2013||Valeant Pharmaceuticals Announces U.S. Approval Of Luzu Cream, 1%|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.